Tubulis

About Tubulis

Tubulis is a company focused on reimagining antibody-drug conjugates (ADCs) with superior biophysical properties for durable on-tumor delivery and long-lasting anti-tumor activity. Their mission is to expand the therapeutic potential of ADCs for solid and hematologic tumors through innovative platform technologies, aiming to solidify leadership in ADC design for their pipeline, partners, and patients.

Products & Services

TUB-040:An ADC candidate targeting NaPi2b, currently being evaluated in the clinic for high-need solid tumor indications.

Tubutecan ADC:A collaborative ADC under a strategic license agreement with BMS, which has entered clinical trials.

Specialties

Antibody-Drug Conjugates (ADCs) Solid and Hematologic Tumor Treatments ADC Platform Technologies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 401000000 MR: - FA: €344M FAN: 401000000	D: 2025-10-30 FD: 2025-10-30	16 investors
2	RT: Series C T: - FT: Series C	A: 361000000 MR: - FA: €308 million FAN: 361000000	D: 2025-10-15 FD: 2025-10-15	13 investors
3	RT: Series B2 T: - FT: Series B2	A: 138800000 MR: - FA: €128 million FAN: 138800000	D: 2024-03-14 FD: 2024-03-14	13 investors

Series C Latest

2025-10-30

$401.0M

16 investors (Pro only)

Series C 2025-10-15

$361.0M

Series B2 2024-03-14

$138.8M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Dominik Schumacher

Chief Executive Officer

LinkedIn (Pro only)

J

Jonas Helma-Smets

Chief Scientific Officer

I

Ingo Lehrke

Chief Business Officer

G

Günter Fingerle-Rowson

Chief Medical Officer

B

Björn Hock

Chief Development Officer

M

Matthew Norkunas

CFO and President Tubulis Inc.

View 113 more team members with Pro

Unlock Full Team Directory

Recent News

Tubulis Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised